Keyphrases
Head-and-neck
100%
Multicenter Clinical Trial
100%
At-risk
100%
Dose Constraints
100%
Intensity-modulated Radiation Therapy
100%
Cumulative Incidence
50%
Central Nervous System
50%
Brainstem
50%
Necrosis
50%
Inner Ear
50%
Myelitis
50%
Optic Nerve Disorders
50%
Organs at Risk
50%
Pharyngeal Constrictor muscles
50%
Prevalence Proportion
50%
Hearing Impaired
50%
DVH Parameters
50%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
25%
Hypothyroidism
25%
Individual Patient Data
25%
Late Toxicity
25%
Nasopharyngeal Carcinoma
25%
Dose-volume Histogram
25%
Eyeball
25%
ROC Analysis
25%
Xerostomia
25%
Dysphagia
25%
Organ-specific
25%
Ancillary
25%
Middle Ear Infection
25%
Parotid Gland
25%
Laryngeal Edema
25%
Optic Nerve
25%
Dmax
25%
Patient Dose
25%
Predicted Toxicity
25%
Medicine and Dentistry
Clinical Trial
100%
Neck
100%
Intensity Modulated Radiation Therapy
100%
Optic Nerve
100%
Disease
66%
Cumulative Incidence
66%
Central Nervous System
66%
Hearing Impairment
66%
Brainstem
66%
Prevalence
66%
Necrosis
66%
Transverse Myelitis
66%
Contralateral
33%
Patient-Data
33%
Hypothyroidism
33%
Middle Ear
33%
Dose-Volume Histogram
33%
Eyeball
33%
Nasopharynx Carcinoma
33%
Xerostomia
33%
Plummer-Vinson Syndrome
33%
Parotid Gland
33%
Thyroid Gland
33%
Larynx Edema
33%
Head and Neck Carcinoma
33%
Otitis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Prevalence
100%
Hearing Impairment
100%
Clinical Trial
100%
Necrosis
100%
Myelitis
100%
Hypothyroidism
50%
Nasopharynx Carcinoma
50%
Xerostomia
50%
Larynx Edema
50%
Dysphagia
50%
Otitis
50%
Dose-Volume Histogram
50%
Head and Neck Carcinoma
50%